Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
63
KPTI Quote, Financials, Valuation and Earnings
Last price:
$7.47
Seasonality move
:
10%
Day range:
$7.32 - $7.54
52-week range:
$3.51 - $12.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.45x
P/B ratio:
--
Volume:
77.2K
Avg. volume:
182.8K
1-year change:
-16.3%
Market cap:
$127.4M
Revenue:
$145.2M
EPS (TTM):
-$14.58
Earnings Data
Next earnings date for KPTI
Feb 19
2026
Most recent earnings per share
-$3.82
Missed by $0.57
(Nov 3/2025)
Consensus Estimate
-$3.25
(Nov 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
KPTI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/19/2026 | Q4 | $35.8M | -- | -- | -$1.93 | -- |
| 11/03/2025 | Q3 | $42.4M | $44M | -$3.82 | -$3.25 | -$0.57 |
| 08/11/2025 | Q2 | $37.9M | $37.9M | -$4.32 | -$3.91 | -$0.41 |
| 05/08/2025 | Q1 | $35.1M | $30M | -$2.77 | -$3.09 | $0.32 |
| 02/19/2025 | Q4 | $35.7M | $30.5M | -$3.67 | -$4.03 | $0.36 |
| 11/05/2024 | Q3 | $37.9M | $38.8M | -$0.26 | -$3.93 | $3.67 |
| 08/06/2024 | Q2 | $36.2M | $42.8M | -$0.20 | -$4.47 | $4.27 |
| 05/08/2024 | Q1 | $34.5M | $33.1M | -$0.32 | -$4.94 | $4.62 |
| 02/29/2024 | Q4 | $33.6M | $33.7M | -$0.36 | -$4.65 | $4.28 |
| 11/02/2023 | Q3 | -- | $36M | -$0.30 | -- | -- |
| 08/02/2023 | Q2 | -- | $37.6M | -$0.29 | -- | -- |
| 05/04/2023 | Q1 | -- | $38.7M | -$0.30 | -- | -- |
| 02/15/2023 | Q4 | -- | $33.6M | -$0.43 | -- | -- |
| 11/03/2022 | Q3 | -- | $36.1M | -$0.45 | -- | -- |
| 08/04/2022 | Q2 | -- | $39.7M | -$0.62 | -- | -- |
| 05/05/2022 | Q1 | -- | $47.7M | -$0.53 | -- | -- |
| 02/08/2022 | Q4 | -- | $126.3M | $0.45 | -- | -- |
| 11/03/2021 | Q3 | -- | $37.7M | -$0.69 | -- | -- |
| 08/05/2021 | Q2 | -- | $22.6M | -$0.71 | -- | -- |
| 05/03/2021 | Q1 | -- | $23.3M | -$0.77 | -- | -- |
| 02/11/2021 | Q4 | -- | $35.1M | -$0.59 | -- | -- |
| 11/02/2020 | Q3 | -- | $21.3M | -$0.73 | -- | -- |
| 08/04/2020 | Q2 | -- | $33.5M | -$0.63 | -- | -- |
| 05/08/2020 | Q1 | -- | $18.1M | -$0.78 | -- | -- |
| 02/13/2020 | Q4 | -- | $18.1M | -$0.76 | -- | -- |
| 11/04/2019 | Q3 | -- | $13.1M | -$0.67 | -- | -- |
| 08/06/2019 | Q2 | -- | $9.5M | -$0.71 | -- | -- |
| 05/09/2019 | Q1 | -- | $155K | -$1.09 | -- | -- |
| 02/28/2019 | Q4 | -- | $206K | -$0.96 | -- | -- |
| 11/08/2018 | Q3 | -- | $239K | -$0.79 | -- | -- |
| 08/07/2018 | Q2 | -- | $19.9M | -$0.60 | -- | -- |
| 05/10/2018 | Q1 | -- | $10M | -$0.78 | -- | -- |
| 03/15/2018 | Q4 | -- | $1.5M | -$0.80 | -- | -- |
| 11/02/2017 | Q3 | -- | -- | -$0.65 | -- | -- |
| 08/08/2017 | Q2 | -- | $3K | -$9.60 | -- | -- |
| 05/04/2017 | Q1 | -- | $68K | -$10.71 | -- | -- |
| 03/16/2017 | Q4 | -- | $47K | -$0.65 | -- | -- |
| 11/07/2016 | Q3 | -- | $48K | -$0.69 | -- | -- |
| 08/04/2016 | Q2 | -- | $59K | -$0.84 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.75 | -- | -- |
| 03/14/2016 | Q4 | -- | $25K | -$0.81 | -- | -- |
Karyopharm Therapeutics, Inc. Earnings Questions
-
How Much did Karyopharm Therapeutics, Inc. Generate in Revenue Last Quarter?
Karyopharm Therapeutics, Inc. reported $44M worth of top line sales in its most recent quarter.
-
Did Karyopharm Therapeutics, Inc. Beat Earnings Last Quarter?
Karyopharm Therapeutics, Inc. announced earnings per share of -$3.82 which represents a miss of analyst forecast a -$3.25 per share.
-
Is Karyopharm Therapeutics, Inc. Profitable?
Karyopharm Therapeutics, Inc. reported $41.8M that represents $4.82 per share over the last quarter.
-
What is the Analyst Consensus for Karyopharm Therapeutics, Inc. EPS Next Year?
Karyopharm Therapeutics, Inc.'s earnings are forecast to decrease from -$9.41 per share to -$9.23 per share next year representing a decrease of -27.94%.
-
When is Karyopharm Therapeutics, Inc.'s Earnings Date?
Karyopharm Therapeutics, Inc.'s next earnings date is February 19, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
